These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10369069)

  • 1. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells.
    Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC
    Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B; Safa AR
    Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.
    Bark H; Choi CH
    Cancer Chemother Pharmacol; 2010 May; 65(6):1131-6. PubMed ID: 19763573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene.
    Strahl BD; Huang HJ; Pedersen NR; Wu JC; Ghosh BR; Miller WL
    Endocrinology; 1997 Jun; 138(6):2621-31. PubMed ID: 9165057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells.
    Zhao B; Yu W; Qian M; Simmons-Menchaca M; Brown P; Birrer MJ; Sanders BG; Kline K
    Mol Carcinog; 1997 Jul; 19(3):180-90. PubMed ID: 9254885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
    Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
    Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib.
    Chen C; Shen HL; Yang J; Chen QY; Xu WL
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):9-17. PubMed ID: 20229271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
    David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
    Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
    Han CY; Cho KB; Choi HS; Han HK; Kang KW
    Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta.
    Gill PK; Gescher A; Gant TW
    Eur J Biochem; 2001 Aug; 268(15):4151-7. PubMed ID: 11488907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
    Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G
    Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the rat atrial natriuretic peptide gene after acute imposition of left ventricular pressure overload.
    Cornelius T; Holmer SR; Müller FU; Riegger GA; Schunkert H
    Hypertension; 1997 Dec; 30(6):1348-55. PubMed ID: 9403552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells.
    Berry A; Goodwin M; Moran CL; Chambers TC
    Biochem Pharmacol; 2001 Sep; 62(5):581-91. PubMed ID: 11585055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells.
    Budworth J; Gant TW; Gescher A
    Br J Cancer; 1997; 75(9):1330-5. PubMed ID: 9155054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.
    Zhao L; Jin X; Xu Y; Guo Y; Liang R; Guo Z; Chen T; Sun Y; Ding X
    J Exp Clin Cancer Res; 2010 Jul; 29(1):98. PubMed ID: 20642825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
    Kim R; Beck WT
    Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
    Petz LN; Ziegler YS; Schultz JR; Nardulli AM
    Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
    Tay DL; Hoffbrand AV; Wickremasinghe GR
    Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.